
, Sang-Jin Park1
, Seong Wook Hong2
1Department of Anesthesiology and Pain Medicine, Yeungnam University College of Medicine, Daegu, Korea
2Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
© 2026 Yeungnam University College of Medicine, Yeungnam University Institute of Medical Science
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
| Age group | Assessment method | Commonly used tools | Key assessment items and features |
|---|---|---|---|
| Neonates and infants (0–1 yr) | Physiological and behavioral observation | CRIES | · CRIES: crying, increased oxygen requirement, vital signs (HR/BP), facial expression, sleeplessness |
| Neonatal Infant Pain Scale (NIPS) | · NIPS: facial expression, cry, breathing pattern, arms, legs, state of arousal | ||
| Premature Infant Pain Profile (PIPP) | -PIPP: gestational age, behavioral state, HR, and oxygen saturation changes, brow bulge, eye squeeze, nasolabial furrow | ||
| Infants and toddlers (1–3 yr) | Behavioral observation | Face, Legs, Activity, Cry, Consolability (FLACC) Scale | · Measures intensity of pain or discomfort |
| · Assesses facial expression, leg movement, activity, cry, consolability | |||
| Preschool children (3–7 yr) | Behavioral observation+self-report | Objective Pain Scale and Comfort Scale (OPSCS) | · Combines observation and simple self-report |
| Facial Pain Scale | - Uses pictorial tools such as facial drawings to help children indicate pain level | ||
| Wong-Baker Faces Pain Rating | |||
| Older children and adolescents (≥7 yr) | Mainly self-report | Visual Analog Scale (VAS) | · Cognitive and linguistic development sufficient for direct pain description |
| Numeric Rating Scale (NRS) | · Pain intensity rated on a 0–10 scale | ||
| Other self-report scales |
| Drug | Typical intravenous dose (μg/kg) | Usual dosing interval (hr) | Notes |
|---|---|---|---|
| Morphine | Bolus: 50–100 | Every 2–4 | Nausea, vomiting, sedation, respiratory depression |
| Fentanyl | Bolus: 0.5–1 | Every 2–4 | More potent than morphine, sedation, respiratory depression |
| Hydromorphone | Bolus: 10–15 | Every 3–6 | Very rapid onset and short duration, chest wall rigidity, sedation, respiratory depression |
| Drug | Typical IV dose | Maximum daily dose | Notes |
|---|---|---|---|
| Acetaminophen | 2–12 yr: 12.5 mg/kg every 4 hr or 15 mg/kg every 6 hr (≥15 min infusion) | 75 mg/kg/day | Use lower daily limit in liver disease, malnutrition |
| ≥13 yr, <50 kg: dosing for children aged 2–12 yr | 3.75 g/day | ||
| ≥13 yr, ≥50 kg: 650 mg every 4 hr or 1,000 mg every 6 hr | 4 g/day | ||
| Ketorolac | 2–16 yr: <50 kg: 0.5 mg/kg IV every 6 hr PRN, max 15 mg per dose | 60 mg/day | Avoid in renal impairment, bleeding risk, GI ulcer, thrombocytopenia |
| ≥50 kg: 30 mg IV every 6 hr PRN, max 30 mg per dose | |||
| Ibuprofen | 6 mo to <12 yr: 5–10 mg/kg every 6 hr (≥15 min infusion) 12–17 yr: 400 mg IV every 6 hr (≥15 min infusion) | 40 mg/kg/day or 2,400 mg/day | Avoid in significant renal dysfunction, active bleeding, platelet dysfunction |
| Local anesthetic | Concentration (%) | Volume (mL/kg) | Maximum dose (mg/kg) | Expected duration (hr) |
|---|---|---|---|---|
| Lidocaine | 1–2 | 0.25 | 3–4 | 1–2 |
| Bupivacaine | 0.2% | 0.5 | 2–2.5 | 6–12 |
| Ropivacaine | 0.2 | 0.5 | 2.5 | 6–12 |
| Levobupivacaine | 0.25 | 0.5 | 2.5 | 6–12 |
| Drug | PCA bolus dose (μg/kg) | Lockout interval (min) | Basal infusion (μg/kg/hr) |
|---|---|---|---|
| Morphine | 10–20 | 6–10 | 10-20 |
| Fentanyl | 0.2–0.3 | 5–10 | 0.3–1 |
| Hydromorphone | 2–4 | 6–10 | 2–4 |
HR, heart rate; BP, blood pressure.
IV, intravenous; PRN, pro re nata; GI, gastrointestinal.